Related Experiment Video
Updated: Jul 6, 2026

Isolation and Culture of Pulmonary Endothelial Cells from Neonatal Mice
Published on: December 14, 2010
Role of matrix metalloproteinase-2 in newborn mouse lungs under hypoxic conditions
Namasivayam Ambalavanan1, Teodora Nicola, Peng Li
1Department of Pediatrics, Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL 35233, USA. ambal@uab.edu
Abstract:
Hypoxia impairs normal neonatal pulmonary artery remodeling and alveolar development. Matrix metalloproteinase-2 (MMP-2), which regulates collagen breakdown, is important during development. Our objective was to test the hypothesis that hypoxia attenuates the normal postnatal increase in MMP-2 and evaluate alveolar development and pulmonary arterial remodeling in Mmp2 mice. C57BL/6 wild-type (WT), Mmp2, Mmp2, and MMP-inhibited (with doxycycline) mice were exposed to hypoxia (12% O2) or air from birth to 2 wk of age. Pulmonary arterial remodeling, alveolar development, and vascular collagen and elastin were evaluated. MMP-2 was estimated by quantitative real-time polymerase chain reaction, enzyme-linked immunosorbent assay, immunohistochemistry, and zymography. We observed that 1) in WT mice, hypoxia led to thicker-walled pulmonary arteries and impaired alveolarization, accompanied by decreased MMP-2 and increased tissue inhibitor of metalloproteinases-2 (TIMP-2); 2) Mmp2 mice in air had thicker-walled arteries, impaired alveolarization, and increased perivascular collagen and elastin compared with WT; 3) hypoxia further inhibited alveolarization but did not alter arterial thickening in Mmp2 mice. Mmp2 and MMP-inhibited mice also had thicker-walled arteries than WT in air, but alveolarization was not different. We conclude that hypoxia reduces the postnatal MMP-2 increase in the lung, which may contribute to abnormal pulmonary arterial remodeling and impaired alveolarization.
Insights
Hypoxia reduces matrix metalloproteinase-2 (MMP-2) in neonatal lungs, impairing pulmonary artery remodeling and alveolar development. This suggests MMP-2 is crucial for normal lung growth after birth.
Area of Science:
- Neonatal physiology
- Pulmonary vascular development
- Matrix metalloproteinases
Background:
- Hypoxia during neonatal development disrupts normal pulmonary artery remodeling and alveolar growth.
- Matrix metalloproteinase-2 (MMP-2) plays a key role in regulating collagen breakdown, essential for tissue development.
Purpose of the Study:
- To investigate if hypoxia attenuates the normal postnatal increase in MMP-2.
- To evaluate the impact of MMP-2 deficiency and inhibition on alveolar development and pulmonary arterial remodeling under normoxia and hypoxia.
Main Methods:
- Mice (wild-type, Mmp2 knockout, and MMP-inhibited) were exposed to hypoxia (12% O2) or air from birth to 2 weeks.
- Pulmonary arterial remodeling, alveolarization, and vascular collagen/elastin content were assessed.
- MMP-2 levels were quantified using RT-PCR, ELISA, immunohistochemistry, and zymography.
Main Results:
- In wild-type mice, hypoxia caused thicker pulmonary arteries, impaired alveolarization, decreased MMP-2, and increased TIMP-2.
- Mmp2 mice exhibited thicker arteries and impaired alveolarization even in air, with further alveolarization inhibition under hypoxia.
- MMP-2 inhibition also led to thicker arteries in air, but without affecting alveolarization.
Conclusions:
- Hypoxia reduces the normal postnatal increase of MMP-2 in the neonatal lung.
- Reduced MMP-2 activity likely contributes to abnormal pulmonary arterial remodeling and impaired alveolar development observed under hypoxic conditions.

